Indications and uses
Helps Prevent Sunburn
Skin Caviar Foundation Sunscreen SPF 15 - Honey Beige
- Manufacturer
- La Prairie, Inc
- Effective date
- 2018-11-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 31
- Source
- full-release
- Hydrated at
- 2026-05-31 22:57:14
Label at a glance#
ProductSkin Caviar Foundation Sunscreen SPF 15 - Honey Beige
Active ingredientOCTINOXATE
Label structure13 sections
Dosage and administration
Apply Daily After Cleansing and Toning Smooth over face and throat Apply liberally 15 minutes before sun exposure Children under 6 months of age: Ask a doctor Reapply at least every 2 hours Use a water resistance sunscreen if swimming or sweating
Contacts and useful links#
Websitewww.laprairie.com
www.laprairie.com
www.laprairie.comLabel contents#
Full prescribing information#
Active Ingredients
Octinoxate 6.0%
Purpose
Sunscreen
Uses
Helps Prevent Sunburn
Warnings
Skin Cancer/Skin Aging Alert: Spending time in the sun increase your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, not skin cancer or early skin aging.
For external use only
Do not use
on damaged or broken skin
When using this product
Keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
rash occurs
Keep out of reach of children
If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
Apply Daily After Cleansing and Toning
Smooth over face and throat
Apply liberally 15 minutes before sun exposure
Children under 6 months of age: Ask a doctor
Reapply at least every 2 hours
Use a water resistance sunscreen if swimming or sweating
Inactive Ingredients
Water (Aqua), Cyclopentasiloxane, Phenyl Trimethicone,
Butylene Glycol, Isononyl Isononanoate, Polysilicone-11, Cyclohexasiloxane,
Ethylhexyl Hydroxystearate, Diisopropyl Dimer Dilinoleate, Glycoproteins*,
Panax Ginseng Root Extract*, Equisetum Arvense Extract*, Palmitoyl Hexapeptide-
14, C18-36 Acid Triglyceride, Caviar Extract, Algae Extract, Glycyrrhiza
Glabra (Licorice) Root Extract, Lactobacillus Ferment, Tocopheryl Acetate, Glycine
Soja (Soybean) Oil, Hydrolyzed Malt Extract, Lactobacillus/Algae Extract Ferment,
PEG/PPG-18/18 Dimethicone, Panthenol, Hydrolyzed Wheat Protein, Arnica
Montana Flower Extract, Ceramide 3, Tocopherol, Glycerin, Hydrogenated Lecithin,
Sodium PCA, Lysine, Proline, Glycine, Arginine, Methionine, Disodium Stearoyl
Glutamate, Petrolatum, Dimethicone, Tocopheryl Linoleate, Ethylhexylglycerin,
Propylene Glycol, Saccharomyces Cerevisiae Extract, Polymethyl Methacrylate,
Lauryl Methacrylate/Glycol Dimethacrylate Crosspolymer, Aluminum Hydroxide,
Xanthan Gum, Trihydroxystearin, Polyglucuronic Acid, Citric Acid, Ethoxydiglycol,
Sodium Chloride, Fragrance (Parfum), Benzyl Alcohol, Linalool, Hydroxycitronellal,
Alpha-Isomethyl Ionone, Amyl Cinnamal, Hexyl Cinnamal, Evernia Furfuracea
(Treemoss) Extract, Geraniol, Citronellol, Benzyl Benzoate, Butylphenyl Methylpropional,
Methylparaben, Propylparaben, Phenoxyethanol, Ethylparaben
May Contain [+/- : Titanium Dioxide (CI 77891), Iron Oxides (CI 77491), Iron Oxides
(CI 77492), Iron Oxides (CI 77499)] i74
Other information
Protect the product in this container from excessive heat and direct sun
Questions or Comments?
Call toll free 1-800-821-5718 or visit www.laprairie.com
Principle Display Panel
Honey Beige
Active Ingredient: Octinoxate 6.0% SEE PACKAGE INSERT FOR WARNING STATEMENT
30 ml e / 1.0 FL. OZ.
MADE IN USA - FABRIQUE AUX ETATS-UNIS
LABORATOIRES LA PRAIRIE S.A CLARENS/MONTREUX • ZURICH D-78530 BADEN-BADEN MILANO • PARIS
LA PRAIRIE, INC. DISTR. NEW YORK, N.Y. 10019
SHAKE WELL / BIEN AGITER
LABORATOIRES LA PRAIRIE S.A., CLARENS/MONTREUX • ZURICH • D-BADEN-BADEN • MILANO • PARIS
LA PRAIRIE, INC., DISTR., NEW YORK, N.Y. 10019
MADE IN USA / FABRIQUE AUX ETATS-UNIS
CONCEALER / ANTI-CERNES 2 g / NET WT. 0.07 OZ.
FOUNDATION / FOND DE TEINT 30 ml e / 1.0 FL. OZ.
SHAKE WELL / BIEN AGITER
SKIN CAVIAR CONCEALER . FOUNDATION SPF 15 la prairie SWITZERLAND 30ml e / 1.0 FL. OZ.
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68026-118-03 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-23b4-a910-e053-dadaa90a0b85 | 20fa7d8b-2bbe-503a-e054-00144ff88e88 |
| 68026-118-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-23b4-a910-e053-dadaa90a0b85 | 20fa7d8b-2bbe-503a-e054-00144ff88e88 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68026-118-03 | Skin Caviar Foundation Sunscreen SPF 15 - Honey Beige | 3 mL in 1 BOTTLE, PLASTIC | LOTION | 3 | 31 | |
| 68026-118-30 | Skin Caviar Foundation Sunscreen SPF 15 - Honey Beige | 30 mL in 1 BOTTLE, PLASTIC | LOTION | 30 | 31 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 30 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 30 | |
| .ALPHA.-AMYLCINNAMALDEHYDE | INACTIVE INGREDIENT | WC51CA3418 | 30 | |
| .ALPHA.-HEXYLCINNAMALDEHYDE | INACTIVE INGREDIENT | 7X6O37OK2I | 30 | |
| .ALPHA.-TOCOPHEROL LINOLEATE, D- | INACTIVE INGREDIENT | G0N132Q0ED | 30 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 30 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 30 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 30 | |
| ARNICA MONTANA FLOWER | INACTIVE INGREDIENT | OZ0E5Y15PZ | 30 | |
| ASIAN GINSENG | INACTIVE INGREDIENT | CUQ3A77YXI | 30 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 30 | |
| BENZYL BENZOATE | INACTIVE INGREDIENT | N863NB338G | 30 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 30 | |
| BUTYLPHENYL METHYLPROPIONAL | INACTIVE INGREDIENT | T7540GJV69 | 30 | |
| C18-36 ACID TRIGLYCERIDE | INACTIVE INGREDIENT | ZRA72DR3R7 | 30 | |
| CAVIAR, UNSPECIFIED | INACTIVE INGREDIENT | 020K6HLU0O | 30 | |
| CERAMIDE 3 | INACTIVE INGREDIENT | 4370DF050B | 30 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 30 | |
| CITRONELLAL | INACTIVE INGREDIENT | QB99VZZ7GZ | 30 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 30 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 30 | |
| DIETHYLENE GLYCOL MONOETHYL ETHER | INACTIVE INGREDIENT | A1A1I8X02B | 30 | |
| DIISOPROPYL DILINOLEATE | INACTIVE INGREDIENT | 5323S7S2LR | 30 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 30 | |
| DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) | INACTIVE INGREDIENT | 9E4CO0W6C5 | 30 | |
| DISODIUM STEAROYL GLUTAMATE | INACTIVE INGREDIENT | 45ASM2L11M | 30 | |
| EQUISETUM ARVENSE BRANCH | INACTIVE INGREDIENT | 1L0VKZ185E | 30 | |
| ETHYLHEXYL HYDROXYSTEARATE | INACTIVE INGREDIENT | B7I80BVV5E | 30 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 30 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 30 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 30 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 30 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 30 | |
| GERANIOL | INACTIVE INGREDIENT | L837108USY | 30 | |
| GLUCURONIC ACID | INACTIVE INGREDIENT | 8A5D83Q4RW | 30 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 30 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 30 | |
| GLYCYRRHIZA GLABRA | INACTIVE INGREDIENT | 2788Z9758H | 30 | |
| HYDROGENATED SOYBEAN LECITHIN | INACTIVE INGREDIENT | H1109Z9J4N | 30 | |
| HYDROLYZED WHEAT PROTEIN (ENZYMATIC, 3000 MW) | INACTIVE INGREDIENT | J2S07SB0YL | 30 | |
| HYDROXYCITRONELLAL | INACTIVE INGREDIENT | 8SQ0VA4YUR | 30 | |
| ISOMETHYL-.ALPHA.-IONONE | INACTIVE INGREDIENT | 9XP4LC555B | 30 | |
| ISONONYL ISONONANOATE | INACTIVE INGREDIENT | S4V5BS6GCX | 30 | |
| LACTOBACILLUS REUTERI | INACTIVE INGREDIENT | 9913I24QEE | 30 | |
| LACTOBACILLUS RHAMNOSUS | INACTIVE INGREDIENT | 9601IVB87J | 30 | |
| LAURYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER | INACTIVE INGREDIENT | EX0F4CZ66H | 30 | |
| LINALOOL, (+/-)- | INACTIVE INGREDIENT | D81QY6I88E | 30 | |
| LYSINE | INACTIVE INGREDIENT | K3Z4F929H6 | 30 | |
| METHIONINE | INACTIVE INGREDIENT | AE28F7PNPL | 30 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 30 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 30 | |
| PEG/PPG-18/18 DIMETHICONE | INACTIVE INGREDIENT | 9H0AO7T794 | 30 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 30 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 30 | |
| PHENYL TRIMETHICONE | INACTIVE INGREDIENT | DR0K5NOJ4R | 30 | |
| POLY(METHYL METHACRYLATE; 450000 MW) | INACTIVE INGREDIENT | Z47NNT4J11 | 30 | |
| PROLINE | INACTIVE INGREDIENT | 9DLQ4CIU6V | 30 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 30 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 30 | |
| PSEUDEVERNIA FURFURACEA | INACTIVE INGREDIENT | 49ZMN09Q0K | 30 | |
| SACCHAROMYCES CEREVISIAE | INACTIVE INGREDIENT | 978D8U419H | 30 | |
| SARGASSUM FILIPENDULA | INACTIVE INGREDIENT | 55P66J5H7N | 30 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 30 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 30 | |
| SOYBEAN OIL | INACTIVE INGREDIENT | 241ATL177A | 30 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 30 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 30 | |
| TRIHYDROXYSTEARIN | INACTIVE INGREDIENT | 06YD7896S3 | 30 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 30 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 30 |
Products#
Every source-derived product name is available through these pages.
- Skin Caviar Foundation Sunscreen SPF 15 - Honey Beige
- Octinoxate 6.0%
- PROPYLPARABEN
- DIETHYLENE GLYCOL MONOETHYL ETHER
- LAURYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER
- DIISOPROPYL DILINOLEATE
- CITRONELLAL
- ISOMETHYL-.ALPHA.-IONONE
- PROPYLENE GLYCOL
- PSEUDEVERNIA FURFURACEA
- BENZYL BENZOATE
- GERANIOL
- ARNICA MONTANA FLOWER
- BUTYLPHENYL METHYLPROPIONAL
- LACTOBACILLUS REUTERI
- SODIUM PYRROLIDONE CARBOXYLATE
- HYDROGENATED SOYBEAN LECITHIN
- HYDROLYZED WHEAT PROTEIN (ENZYMATIC, 3000 MW)
- GLYCINE
- CAVIAR, UNSPECIFIED
- GLYCYRRHIZA GLABRA
- SACCHAROMYCES CEREVISIAE
- ASIAN GINSENG
- XANTHAN GUM
- LYSINE
- ARGININE
- ETHYLHEXYLGLYCERIN
- EQUISETUM ARVENSE BRANCH
- GLUCURONIC ACID
- PROLINE
- CITRIC ACID MONOHYDRATE
- METHIONINE
- TITANIUM DIOXIDE
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- ALPHA-TOCOPHEROL ACETATE
- GLYCERIN
- DIMETHICONE
- LACTOBACILLUS RHAMNOSUS
- TOCOPHEROL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68026-118 | 68026-118-30, 68026-118-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SYSTEM / TOPICAL | 42 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | SUSPENSION, EXTENDED RELEASE / ORAL | 2.7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / AURICULAR (OTIC) | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| PROLINE | PROLINE | 9DLQ4CIU6V | INJECTION, SOLUTION / INTRAVENOUS | 0.34 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| SOYBEAN OIL | SOYBEAN OIL | 241ATL177A | SOLUTION / TOPICAL | 5.82 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | PASTE, DENTIFRICE / DENTAL | 0.05 %w/w | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUPPOSITORY / VAGINAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SUBCUTANEOUS | 22 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| HYDROGENATED SOYBEAN LECITHIN | HYDROGENATED SOYBEAN LECITHIN | H1109Z9J4N | SUSPENSION / AURICULAR (OTIC) | 0.15 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 8.4 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 0.86 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | POWDER / RESPIRATORY (INHALATION) | 0.04 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTICULAR | 26 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | CAPSULE / ORAL | NA | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SUBCUTANEOUS | 2 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRALESIONAL | 13 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION / INTRAVENOUS | 200 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVENOUS | 0.9 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION, EXTENDED RELEASE / ORAL | 186.8 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| PEG/PPG-18/18 DIMETHICONE | PEG/PPG-18/18 DIMETHICONE | 9H0AO7T794 | GEL / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 360 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED PELLETS / ORAL | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | ENEMA / RECTAL | 150 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRACAVITARY | 0.01 ml | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, EXTENDED RELEASE / ORAL | 7 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRALESIONAL | 20 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRACAUDAL | 210 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, EXTENDED RELEASE / ORAL | 67 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / SUBCUTANEOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7a7dc3d5-040b-80b7-e053-2991aa0acc41 | 20fa7d8b-2bbe-503a-e054-00144ff88e88 | 2018-11-12 | Warnings | 7a7dc3d5-040b-80b7-e053-2991aa0acc41 20fa7d8b-2bbe-503a-e054-00144ff88e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.